These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32360637)

  • 21. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
    Khoury T; Ben Ya'acov A; Shabat Y; Zolotarovya L; Snir R; Ilan Y
    World J Gastroenterol; 2015 Jun; 21(24):7443-56. PubMed ID: 26139990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auto-aggressive CXCR6
    Dudek M; Pfister D; Donakonda S; Filpe P; Schneider A; Laschinger M; Hartmann D; Hüser N; Meiser P; Bayerl F; Inverso D; Wigger J; Sebode M; Öllinger R; Rad R; Hegenbarth S; Anton M; Guillot A; Bowman A; Heide D; Müller F; Ramadori P; Leone V; Garcia-Caceres C; Gruber T; Seifert G; Kabat AM; Mallm JP; Reider S; Effenberger M; Roth S; Billeter AT; Müller-Stich B; Pearce EJ; Koch-Nolte F; Käser R; Tilg H; Thimme R; Boettler T; Tacke F; Dufour JF; Haller D; Murray PJ; Heeren R; Zehn D; Böttcher JP; Heikenwälder M; Knolle PA
    Nature; 2021 Apr; 592(7854):444-449. PubMed ID: 33762736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 3-week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell death.
    Briand F; Heymes C; Bonada L; Angles T; Charpentier J; Branchereau M; Brousseau E; Quinsat M; Fazilleau N; Burcelin R; Sulpice T
    Clin Transl Sci; 2020 May; 13(3):529-538. PubMed ID: 31981449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.
    Maricic I; Marrero I; Eguchi A; Nakamura R; Johnson CD; Dasgupta S; Hernandez CD; Nguyen PS; Swafford AD; Knight R; Feldstein AE; Loomba R; Kumar V
    J Immunol; 2018 Nov; 201(10):3017-3035. PubMed ID: 30322964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin β
    Guo Q; Furuta K; Lucien F; Gutierrez Sanchez LH; Hirsova P; Krishnan A; Kabashima A; Pavelko KD; Madden B; Alhuwaish H; Gao Y; Revzin A; Ibrahim SH
    J Hepatol; 2019 Dec; 71(6):1193-1205. PubMed ID: 31433301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
    Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis.
    Chackelevicius CM; Gambaro SE; Tiribelli C; Rosso N
    World J Gastroenterol; 2016 Nov; 22(41):9096-9103. PubMed ID: 27895397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Gomes AL; Teijeiro A; Burén S; Tummala KS; Yilmaz M; Waisman A; Theurillat JP; Perna C; Djouder N
    Cancer Cell; 2016 Jul; 30(1):161-175. PubMed ID: 27411590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The immunoregulatory effects of CD8 T-cell-derived perforin on diet-induced nonalcoholic steatohepatitis.
    Wang T; Sun G; Wang Y; Li S; Zhao X; Zhang C; Jin H; Tian D; Liu K; Shi W; Tian Y; Zhang D
    FASEB J; 2019 Jul; 33(7):8490-8503. PubMed ID: 30951375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nicotine alleviates the liver inflammation of non-alcoholic steatohepatitis induced by high-fat and high-fructose in mice].
    Chen XM; Li FQ; Yan S; Wu XC; Tang CL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):777-782. PubMed ID: 27752155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
    Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA
    J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptor 3 ablation prevented high-fat diet-induced obesity and metabolic disorder.
    Zhang G; Li R; Li W; Yang S; Sun Q; Yin H; Wang C; Hou B; Wang H; Yu L; Chen R; Shi L; Zhang K; Liew CW; Qiang G; Sun Q; Liu C
    J Nutr Biochem; 2021 Sep; 95():108761. PubMed ID: 33965533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of CD40 on CD11c
    Aarts S; Reiche M; den Toom M; Gijbels M; Beckers L; Gerdes N; Lutgens E
    Sci Rep; 2019 Oct; 9(1):14702. PubMed ID: 31604965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice.
    Bijnen M; Josefs T; Cuijpers I; Maalsen CJ; van de Gaar J; Vroomen M; Wijnands E; Rensen SS; Greve JWM; Hofker MH; Biessen EAL; Stehouwer CDA; Schalkwijk CG; Wouters K
    Gut; 2018 Jul; 67(7):1317-1327. PubMed ID: 29074725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition.
    Krishnan A; Abdullah TS; Mounajjed T; Hartono S; McConico A; White T; LeBrasseur N; Lanza I; Nair S; Gores G; Charlton M
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G666-G680. PubMed ID: 28232454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose.
    Sun G; Jackson CV; Zimmerman K; Zhang LK; Finnearty CM; Sandusky GE; Zhang G; Peterson RG; Wang YJ
    BMC Gastroenterol; 2019 Mar; 19(1):41. PubMed ID: 30885145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis.
    Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA
    Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders.
    Onofrio LI; Arocena AR; Paroli AF; Cabalén ME; Andrada MC; Cano RC; Gea S
    PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003464. PubMed ID: 25668433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH).
    Jindal A; Bruzzì S; Sutti S; Locatelli I; Bozzola C; Paternostro C; Parola M; Albano E
    Exp Mol Pathol; 2015 Aug; 99(1):155-62. PubMed ID: 26112094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.